View Section: Price ratios
Veerhealth Statements
51
Veerhealth Income Statement
B
M
INR (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
2023-09-30
%
74.092
100
48.631
67
25.461
33
—
0
5.88
8
22.515
32
2.946
1
—
0
5.601
10.8
8.547
11.8
1.2
1.6
7.347
10.3
0.355
20.699
2023-03-31
%
64.886
100
44.524
69.2
20.362
30.8
—
0
4.809
5.6
18.442
25.9
1.92
5
—
0
6.269
7.4
8.189
12.4
-5.33
-15.02
13.519
27.4
0.741
17.162
2022-09-30
%
67.847
100
46.318
72
21.529
28
—
0
4.212
5.2
23.199
33.7
-1.67
-5.7
—
0
4.649
10.6
2.979
4.8
0.679
1.3
2.3
3.5
0.31
7.474
2022-03-31
%
46.642
100
34.065
70.7
12.577
29.3
—
0
5.346
14.9
21.811
62.6
-9.234
-33.3
—
0
10.668
31.1
1.434
-2.2
2.972
14
-1.538
-16.1
-0.231
6.811
2021-09-30
%
49.619
100
36.009
74.7
13.61
25.3
—
0
3.428
7
18.675
38.8
-5.065
-13.4
—
0
6.006
14.9
0.941
1.4
0.14
0.2
0.801
1.2
0.11
7.35
View Section: Balance Sheet